Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma

NCT00034554 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00034554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of gp75 DNA Vaccine in Patients With AJCC Stage III and IV Melanoma
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2002
Completion date
September 30, 2004
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma